Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vulnerable plaques and patients: state-of-the-art.
Tomaniak M, Katagiri Y, Modolo R, de Silva R, Khamis RY, Bourantas CV, Torii R, Wentzel JJ, Gijsen FJH, van Soest G, Stone PH, West NEJ, Maehara A, Lerman A, van der Steen AFW, Lüscher TF, Virmani R, Koenig W, Stone GW, Muller JE, Wijns W, Serruys PW, Onuma Y. Tomaniak M, et al. Eur Heart J. 2020 Aug 14;41(31):2997-3004. doi: 10.1093/eurheartj/ehaa227. Eur Heart J. 2020. PMID: 32402086 Free PMC article.
Third-Generation Sirolimus-Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes-a FANTOM STEMI Pilot Study.
Koltowski L, Tomaniak M, Ochijewicz D, Opolski G, Kochman J. Koltowski L, et al. Among authors: tomaniak m. Cardiovasc Drugs Ther. 2023 Jan 14. doi: 10.1007/s10557-023-07429-0. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 36640215
Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone.
Chichareon P, Katagiri Y, Asano T, Takahashi K, Kogame N, Modolo R, Tenekecioglu E, Chang CC, Tomaniak M, Kukreja N, Wykrzykowska JJ, Piek JJ, Serruys PW, Onuma Y. Chichareon P, et al. Among authors: tomaniak m. Expert Rev Med Devices. 2019 Mar;16(3):211-228. doi: 10.1080/17434440.2019.1573142. Epub 2019 Feb 8. Expert Rev Med Devices. 2019. PMID: 30676121 Review.
Interventional cardiology 2018: the year in review.
Komiyama H, Modolo R, Chang CC, Chichareon P, Kogame N, Takahashi K, Tomaniak M, Onuma Y, Cuisset T, Fajadet J, Amin H, Al Rashdan I, Serruys PW. Komiyama H, et al. Among authors: tomaniak m. EuroIntervention. 2019 Apr 5;14(18):e1861-e1878. doi: 10.4244/EIJ-D-19-00040. EuroIntervention. 2019. PMID: 30834898 Free article. Review. No abstract available.
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.
Chichareon P, Modolo R, van Klaveren D, Takahashi K, Kogame N, Chang CC, Katagiri Y, Tomaniak M, Asano T, Spitzer E, Buszman P, Prokopczuk J, Fath-Ordoubadi F, Buysschaert I, Anderson R, Oldroyd KG, Merkely B, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Onuma Y, Serruys PW. Chichareon P, et al. Among authors: tomaniak m. Int J Cardiol. 2019 Jul 1;286:43-50. doi: 10.1016/j.ijcard.2019.02.043. Epub 2019 Feb 20. Int J Cardiol. 2019. PMID: 30846254 Clinical Trial.
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.
Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang CC, Spitzer E, Walsh SJ, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen JGP, Rademaker-Havinga T, Garg S, Steg PG, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt FWA. Serruys PW, et al. Among authors: tomaniak m. EuroIntervention. 2019 Dec 20;15(12):e1090-e1098. doi: 10.4244/EIJ-D-19-00202. EuroIntervention. 2019. PMID: 30888959 Free article. Clinical Trial.
Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study.
Kogame N, Modolo R, Tomaniak M, Cavalcante R, de Martino F, Tinoco J, Ribeiro EE, Mehran R, Campos CM, Onuma Y, Lemos PA, Serruys PW; Collaborators. Kogame N, et al. Among authors: tomaniak m. EuroIntervention. 2019 Aug 9;15(6):e547-e550. doi: 10.4244/EIJ-D-19-00131. EuroIntervention. 2019. PMID: 31012851 Free article. No abstract available.
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study.
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman PP, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska JJ, Wijns W, de Winter RJ, Buszman PE, Onuma Y, Serruys PW. Milewski K, et al. Among authors: tomaniak m. EuroIntervention. 2021 Feb 19;16(14):1187-1194. doi: 10.4244/EIJ-D-18-01201. EuroIntervention. 2021. PMID: 31062697 Free PMC article.
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.
Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW. Chichareon P, et al. Among authors: tomaniak m. EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184. EuroIntervention. 2019. PMID: 31217143 Free article. Clinical Trial.
123 results